Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Biotechnology

Esperion Therapeutics, Inc. develops and markets medical devices. The Company produces oral and small molecule therapies for the treatment of patients with elevated levels of low-density lipoprotein cholesterol and other cardio metabolic risk factors.
Website: esperion.com


Growth: Good revenue growth rate >200%, there is acceleration compared to average historical growth rates 60.5%. The revenue growth dynamics is moderately stable

Profitability: LTM EBITDA margin is negative, -13.9%. On average the margin is improving steadily. Gross margin is high, +92.7%. In the last quarter the company did not beat the estimated EPS. The company was ahead of estimated EPS in 60% of quarters (showing a gain of +$0.01 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield -7.3% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 198.5% higher than minimum and 91.7% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 10.1x by EV / Sales multiple , the company can be >100% undervalued

Key Financials (Download financials)

Ticker: ESPR
Share price, USD:  (0.0%)2.18
year average price 1.76  


year start price 1.76 2023-05-17

min close price 0.73 2023-10-26

max close price 3.24 2024-04-05

current price 2.18 2024-05-15
Common stocks: 169 258 564
Dividend Yield:  0.0%
Last revenue growth (y/y):  > 200.0%
Last growth of EBITDA (y/y):  ---
Historical revenue growth:  60.5%
Historical growth of EBITDA:  6.3%
EV / Sales: 2.1x
Margin (EBITDA LTM / Revenue): -13.9%
Fundamental value created in LTM:
Market Cap ($m): 369
Net Debt ($m): 125
EV (Enterprise Value): 494
Price to Book: -1.3x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics